Randall E. Woods
Amministratore Delegato presso Tychan Pte Ltd.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Steven W. Spector | M | 59 |
Eden Woods Investments LLC
 Eden Woods Investments LLC Financial ConglomeratesFinance Eden Woods Investments LLC provides investment services. The company was founded on May 5, 2011 and is headquartered in Rancho Santa Fe, CA. | 23 anni |
| Donald W. Joseph | M | - |
Sorbent Therapeutics, Inc.
 Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | 19 anni |
| James Healy | M | 59 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Scott Minick | M | 72 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| David G. Lowe | M | 67 |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | 18 anni |
| Markus Goebel | M | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Ming-Kian Teo | M | 72 |
Tychan Pte Ltd.
 Tychan Pte Ltd. BiotechnologyHealth Technology Tychan Pte Ltd. is a clinical-stage biotechnology company based in Singapore that focuses on developing life-saving treatments for emerging infections through disruptive technologies. Tychan was founded by Professor Ram Sasisekharan of Massachusetts Institute of Technology (MIT)/Singapore MIT Alliance for Research and Technology (SMART) and Professor Ooi Eng Eong of Duke-National University of Singapore (Duke-NUS) Medical School, both of whom have expertise in biologics development and biology of acute viral infections. The private company is based in Singapore, Singapore, and Randall E. Woods has been the CEO of the company since 2021. The Singaporean company works closely with regulatory authorities to accelerate the translation from non-clinical studies to clinical trials for emerging pathogens. Temasek Holdings is the founding investor of Tychan. | 8 anni |
| Fidah bin Ismail Alsagoff | M | - |
Tychan Pte Ltd.
Tychan Pte Ltd. BiotechnologyHealth Technology Tychan Pte Ltd. is a clinical-stage biotechnology company based in Singapore that focuses on developing life-saving treatments for emerging infections through disruptive technologies. Tychan was founded by Professor Ram Sasisekharan of Massachusetts Institute of Technology (MIT)/Singapore MIT Alliance for Research and Technology (SMART) and Professor Ooi Eng Eong of Duke-National University of Singapore (Duke-NUS) Medical School, both of whom have expertise in biologics development and biology of acute viral infections. The private company is based in Singapore, Singapore, and Randall E. Woods has been the CEO of the company since 2021. The Singaporean company works closely with regulatory authorities to accelerate the translation from non-clinical studies to clinical trials for emerging pathogens. Temasek Holdings is the founding investor of Tychan. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Howard C. Dittrich | M | 71 |
Sequel Pharmaceuticals, Inc.
 Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sequel Pharmaceuticals, Inc. engaged in the development of cardiovascular drug. The company was founded in 2007 and was headquartered in San Diego, CA.
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | 13 anni |
| Jack Lief | M | 78 | 18 anni | |
| Amit Munshi | M | 56 | 6 anni | |
| Craig M. Audet | M | 59 | 5 anni | |
| Garry Neil | M | 70 | 5 anni | |
| Eckard Weber | M | 73 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | 6 anni |
| Dominic P. Behan | M | 59 | 19 anni | |
| Christopher Cabell | M | 54 | 3 anni | |
| John E. Crawford | M | 69 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA.
Corvas International, Inc.
| 13 anni |
| Thomas O'Neil | M | 59 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Oliver Fetzer | M | 60 | 5 anni | |
| Brian K. Farmer | M | - |
Sequel Pharmaceuticals, Inc.
Sequel Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Sequel Pharmaceuticals, Inc. engaged in the development of cardiovascular drug. The company was founded in 2007 and was headquartered in San Diego, CA.
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | 7 anni |
| Phillip Schneider | M | 68 | 11 anni | |
| Jennifer Jarrett | F | 53 | 5 anni | |
| Scott H. Bice | M | 81 | 15 anni | |
| Kieran Gallahue | M | 60 | 4 anni | |
| Christine Anna White | M | 72 | 12 anni | |
| David Kabakoff | M | 76 |
Corvas International, Inc.
| 7 anni |
| Donald D. Belcher | M | 84 | 14 anni | |
| Manmeet Singh Soni | M | 46 | 3 anni | |
| Jeff S. Williams | M | - |
Boehringer Mannheim Pharmaceuticals Corp.
| 5 anni |
| Joan Schmidt | F | 60 | - | |
| Jayson Dallas | M | 56 | 5 anni | |
| Linda Ara | F | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Kevin Lind | M | 47 | 4 anni | |
| Julie Iwashita | F | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | 3 anni |
| Paul Audhya | M | 51 | 3 anni | |
| Jennifer Kathleen Bielasz | F | 61 | 15 anni | |
| Preston Klassen | M | 55 | 3 anni | |
| Gregory L. Erny | M | - |
Ball State University (Indiana)
| 4 anni |
| Laura G. Hansen | M | - |
Corvas International, Inc.
| 1 anni |
| Ronald Shazer | M | 56 | 1 anni | |
| Mark Withrow Harris | M | - |
Ball State University (Indiana)
| 3 anni |
| Randy Alsman | M | - |
Ball State University (Indiana)
| 4 anni |
| Laurie Stelzer | F | 56 | 2 anni | |
| Megan Knight | F | - | 4 anni | |
| Cate Scanlon | F | - | - | |
| John Adams | M | - | - | |
| Amy Broidrick | F | 66 | 2 anni | |
| Zheng Wei | M | 61 | 4 anni | |
| Thomas Gilliom | M | - |
Ball State University (Indiana)
| 4 anni |
| Steven S. Hall | M | - |
Ball State University (Indiana)
| 4 anni |
| Robert Lisicki | M | 57 | 4 anni | |
| Nina Kjellson | F | 49 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | - |
| Alan Glicklich | M | - | 1 anni | |
| Glen O. Mason | M | - |
Ball State University (Indiana)
| 1 anni |
| Michael L. Cox | M | 79 |
Ball State University (Indiana)
| 4 anni |
| Chadwick J. Orevillo | M | - | 3 anni | |
| Robert Hoffman | M | 58 | 18 anni | |
| Louis J. Scotti | M | 68 | 12 anni | |
| Daniel Passeri | M | 63 |
Boehringer Mannheim Pharmaceuticals Corp.
| 2 anni |
| David C. Reid | M | 74 |
Ball State University (Indiana)
| 4 anni |
| Melvin E. Miller | M | 74 |
Ball State University (Indiana)
| 2 anni |
| Richard Conwell | M | 73 |
Ball State University (Indiana)
| 4 anni |
| Jeffrey P. Rodewald | M | 69 |
Ball State University (Indiana)
| 4 anni |
| J. Wayne Leonard | M | 72 |
Ball State University (Indiana)
| 4 anni |
| Susan B. Bayh | F | 64 |
Corvas International, Inc.
| 3 anni |
| Carl L. Chapman | M | 68 |
Ball State University (Indiana)
| 4 anni |
| Jay Shepard | M | 66 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Eugene B. Habecker | M | - |
Ball State University (Indiana)
| 1 anni |
| William R. Shanahan | M | 74 | 12 anni | |
| Michael J. B. Tansey | M | 75 |
NovaCardia, Inc.
NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | 2 anni |
| Khalid Abdul Mohsen Al-Babtain | M | 76 |
Ball State University (Indiana)
| 4 anni |
| David Collier | M | 61 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| J. Richard Wagers | M | - |
Ball State University (Indiana)
| 4 anni |
| Vernon Bernardino | M | - |
Corvas International, Inc.
| 5 anni |
| Terri Matchett | F | - |
Ball State University (Indiana)
| 4 anni |
| David Walsey | M | - | 4 anni | |
| Bill Rote | M | 61 |
Corvas International, Inc.
| 10 anni |
| Julie A. Crawford | F | - |
Corvas International, Inc.
| 13 anni |
| Gary F. Blackburn | M | - |
Boehringer Mannheim Pharmaceuticals Corp.
| 2 anni |
| Vincent Aurentz | M | 56 | 6 anni | |
| William Waddill | M | 67 |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Jason D. Levin | M | - |
Sorbent Therapeutics, Inc.
Sorbent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sorbent Therapeutics, Inc. develops therapies for cardiovascular and renal diseases. It focuses on the development of non-absorbed polymeric drugs to satisfy unmet clinical needs in large cardiovascular and renal markets such as heart failure, chronic kidney disease and hypertension. The company was founded by William R. Rajski, Dean Abrassart, Donald W. Joseph and Lee W. Henderson on January 25, 2005 and is headquartered in Sunnyvale, CA. | - |
| Suzanne Zoumaras | F | 60 | 3 anni | |
| Joanne Quan | M | 60 | 2 anni | |
| Kimberly Ann Davis | F | 56 | 2 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 83 | 97.65% |
| Singapore | 2 | 2.35% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Randall E. Woods
- Contatti personali
